Biotinylation sites of tumor necrosis factor-α determined by liquid chromatography-mass spectrometry

被引:6
作者
Magni, F [1 ]
Curnis, F
Marazzini, L
Colombo, R
Sacchi, A
Corti, A
Kienle, MG
机构
[1] IRCCS S Raffaele, Mass Spectrometry Lab, Milan, Italy
[2] Ist Sci San Raffaele, DIBIT, Milan, Italy
[3] Univ Milano Bicocca, Dept Med Chem & Biochem, Milan, Italy
[4] Univ Sacred Heart, I-20123 Milan, Italy
关键词
tumor necrosis factor; mass spectrometry; biotin; tumor therapy; electrospray; HPLC;
D O I
10.1006/abio.2001.5374
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Tumor pretargeting with biotinylated antibody/avidin complexes improves the therapeutic index of systemically administered biotin-tumor necrosis factor (TNF) conjugates. Since the number of biotins in this conjugate is known to be critical for activity, we have characterized the structure of different biotin-TNF conjugates, prepared by reaction with D-biotinyl-6-aminocaproic acid N-hydroxysuccinimide ester and identified the biotinylation sites by trypsin digestion, reverse-phase chromatography, and electrospray mass spectrometry analyses. The results have shown that N-terminal valine is a preferential biotinylation site at pH 5.8, half of biotins being located on the alpha -amino group of this residue in a conjugate bearing one biotin/trimer (on average). Moreover, evidence has been obtained to suggest that the remaining part of biotins are linked to the E-amino group of lysine 128, 112, and 65, while lysine 11, 90, and 98 were practically unmodified. No evidence of O-biotinylation of serine, threonine and tyrosine was obtained. (C) 2001 Academic Press.
引用
收藏
页码:181 / 188
页数:8
相关论文
共 21 条
[1]  
Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93
[2]  
[Anonymous], BIOL THERAPY CANC
[3]  
Corti A, 1998, CANCER RES, V58, P3866
[4]   TUMOR-NECROSIS-FACTOR (TNF)-ALPHA QUANTIFICATION BY ELISA AND BIOASSAY - EFFECTS OF TNF-ALPHA-SOLUBLE TNF-RECEPTOR (P55) COMPLEX DISSOCIATION DURING ASSAY INCUBATIONS [J].
CORTI, A ;
POIESI, C ;
MERLI, S ;
CASSANI, G .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 177 (1-2) :191-198
[5]  
FRAKER DL, 1995, BIOL THERAPY CANC, P329
[6]  
Gasparri A, 1999, CANCER RES, V59, P2917
[7]  
Happersberger HP, 1998, PROTEINS, P50
[8]  
HOCHHAUS G, 1988, J BIOL CHEM, V263, P92
[9]   Labeling and identification of the postulated acid/base catalyst in the α-glucosidase from Saccharomyces cerevisiae using a novel bromoketone C-glycoside [J].
Howard, S ;
Withers, SG .
BIOCHEMISTRY, 1998, 37 (11) :3858-3864
[10]   STRUCTURE OF TUMOR NECROSIS FACTOR [J].
JONES, EY ;
STUART, DI ;
WALKER, NPC .
NATURE, 1989, 338 (6212) :225-228